OFLOXACIN - SERUM AND SKIN BLISTER FLUID PHARMACOKINETICS IN THE FASTING AND NONFASTING STATE

被引:25
作者
KALAGER, T
DIGRANES, A
BERGAN, T
ROLSTAD, T
机构
[1] HAUKELAND HOSP, GADE INST, DEPT MED B, BERGEN, NORWAY
[2] HAUKELAND HOSP, DEPT MICROBIOL & IMMUNOL, BERGEN, NORWAY
[3] NORSKE HOECHST, DEPT CLIN RES, OSLO, NORWAY
[4] UNIV OSLO, INST PHARM, DEPT MICROBIOL, OSLO 3, NORWAY
关键词
D O I
10.1093/jac/17.6.795
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Using an agar well diffusion assay, the concentration of ofloxacin were measured in serum and skin blister fluid after an oral dose of 300 mg given with or without a standardized meal. The apparent lag time was longer when the drug was taken with food than in the fasting stage and the serum peak concentrations occurred later; the rates of absorption being 1.72 .+-. 1.12/h (S.D.) and 3.40 .+-. 1.56/h respectively. The mean peak concentrations of each individual in serum and blister fluid were 3.8 .+-. 1.6 mg/l and 1.7 .+-. 0.5 mg/l, respectively, when the drug was taken with food, compared with 4.2 .+-. 1.9 mg/l and 2.1 .+-. 0.7 mg/l in the fasting state. The rate of penetration into blister fluid was not influenced by the intake of food. The elimination half-life was 9.0 .+-. 6.2 h in serum and 13.5 .+-. 7.8 h in blister fuid when the volunteers were fasting. The corresponding values in the non-fasting state were 6.3 .+-. 5.5 h and 10.6 .+-. 4.6 h. The ratio of the area under the concentration versus time curve (AUC0-.chi.) for blister fluid and serum was 1.20 .+-. 0.70 when ofloxacin was given without food and 1.03 .+-. 0.34 when given with the meal.
引用
收藏
页码:795 / 800
页数:6
相关论文
共 10 条
[1]  
DAGROSA EE, 1984, 4TH MED C CHEM RHOD, P33
[2]  
DENT J, 1984, 4TH MED C CHEM RHOD, P432
[3]   INVITRO ACTIVITIES OF CIPROFLOXACIN, OFLOXACIN, NORFLOXACIN AND ROSOXACIN COMPARED WITH CINOXACIN AND TRIMETHOPRIM [J].
DIGRANES, A ;
DIBB, WL ;
BENONISEN, E .
CHEMOTHERAPY, 1985, 31 (06) :466-471
[4]  
GRIMM H, 1984, 4TH MED C CHEM RHOD, P418
[5]  
KING A, 1984, 4TH MED C CHEM RHOD, P413
[6]  
KUMADA T, 1983, 13TH P INT C CHEM
[7]  
SCHREINER A, 1978, SCANDINAVIAN J INF S, V14, P228
[8]   COMPARISON OF THE ANTI-BACTERIAL INVITRO AND INVIVO ACTIVITY OF OFLOXACIN (HOE-280 DL-8280) AND NALIDIXIC-ACID ANALOGS [J].
SEIBERT, G ;
LIMBERT, M ;
KLESEL, N .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (06) :548-553
[9]  
WAGNER JG, 1975, FUNDAMENTALS CLIN PH, P403
[10]  
WALDHAUSL W, 1984, HOE 280 INFLUENCE FO